TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T15601 XX ID T15601 XX DT 10.03.2005 (created); nvo. DT 15.06.2016 (updated); sup. CO Copyright (C), QIAGEN. XX FA AR XX SY AIS; androgen receptor; androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease); AR; DHTR; dihydrotestosterone receptor; HUMARA; HYSP1; KD; KD, Kennedy disease; NR3C4; RP11-383C12.1; SBMA; SMAX1; spinal and bulbar muscular atrophy; testicular feminization; TFM. XX OS Mammalia OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia XX IN T06598 AML-1; mouse, Mus musculus. IN T14315 AML1; Mammalia. IN T08443 AML3; mouse, Mus musculus. IN T08487 AR-isoform1; human, Homo sapiens. IN T14095 ATF-3; Mammalia. IN T02872 beta-catenin; human, Homo sapiens. IN T14513 beta-catenin; Mammalia. IN T09446 c-Jun; Mammalia. IN T08664 C/EBPalpha; Mammalia. IN T09410 C/EBPbeta; Mammalia. IN T15118 CBP; Mammalia. IN T01542 E2F-1; human, Homo sapiens. IN T01546 E2F-4; human, Homo sapiens. IN T14623 Ebp1; Mammalia. IN T19299 Epicardin; mouse, Mus musculus. IN T09637 ER-alpha; Mammalia. IN T16015 ER-beta; Mammalia. IN T13995 ER81; Mammalia. IN T16720 Erg; Mammalia. IN T14067 FOXO1A; Mammalia. IN T21852 HDAC1; Mammalia. IN T08612 HNF-4alpha; Mammalia. IN T30468 jdp2; Mammalia. IN T32445 Ku70; Mammalia. IN T32444 Ku80; Mammalia. IN T25008 pRb; Mammalia. IN T10138 SF-1; Mammalia. IN T23097 Slim-3; Mammalia. IN T09538 Smad3; Mammalia. IN T04689 SMRT; human, Homo sapiens. IN T08326 Sp1; Mammalia. IN T21552 SRC-1; Mammalia. IN T14458 STAT3; Mammalia. IN T16010 TCF-4; Mammalia. IN T19142 TR2; human, Homo sapiens. IN T10019 TR4; Mammalia. XX MX M00481 V$AR_01. MX M00953 V$AR_02. MX M00956 V$AR_03. MX M01201 V$AR_04. MX M00447 V$AR_Q2. MX M00962 V$AR_Q6. MX M01996 V$AR_Q6_01. XX BS R35636. BS R35634. BS R66438. BS R66439. BS R32395. BS R57492. BS R24833. BS R34878. BS R39017. BS R39283. BS R57333. BS R39274. BS R39282. BS R35633. BS R34994. BS R34995. BS R34996. BS R34997. BS R34998. BS R60373. BS R72094. BS R26441. BS R26442. BS R57145. BS R58837. BS R61226. BS R26023. XX DR TRANSPATH: MO000048046. XX RN [1]; RE0016528. RX PUBMED: 9482670. RA Ding X. F., Anderson C. M., Ma H., Hong H., Uht R. M., Kushner P. J., Stallcup M. R. RT Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities RL Mol. Endocrinol. 12:302-313 (1998). RN [2]; RE0016738. RX PUBMED: 11223178. RA Haendler B., Schuttke I., Schleuning W. D. RT Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3eta RL Mol. Cell. Endocrinol. 173:63-73 (2001). RN [3]; RE0025505. RX PUBMED: 12482965. RA Li P., Lee H., Guo S., Unterman T. G., Jenster G., Bai W. RT AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. RL Mol. Cell. Biol. 23:104-118 (2003). RN [4]; RE0027437. RX PUBMED: 10734072. RA Lee D. K., Duan H. O., Chang C. RT From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. RL J. Biol. Chem. 275:9308-13 (2000). RN [5]; RE0027854. RX PUBMED: 11117529. RA Kotaja N., Aittomaki S., Silvennoinen O., Palvimo J. J., Janne O. A. RT ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. RL Mol. Endocrinol. 14:1986-2000 (2000). RN [6]; RE0028255. RX PUBMED: 11439351. RA Gross M., Liu B., Tan J., French F. S., Carey M., Shuai K. RT Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. RL Oncogene 20:3880-7 (2001). RN [7]; RE0028767. RX PUBMED: 11518798. RA Jorgensen J. S., Nilson J. H. RT AR Suppresses Transcription of the alpha Glycoprotein Hormone Subunit Gene Through Protein-Protein Interactions with cJun and Activation Transcription Factor 2. RL Mol. Endocrinol. 15:1496-504 (2001). RN [8]; RE0029026. RX PUBMED: 11682623. RA Sharma M., Sun Z. RT 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. RL Mol. Endocrinol. 15:1918-28 (2001). RN [9]; RE0029628. RX PUBMED: 11994312. RA Gaughan L., Logan I. R., Cook S., Neal D. E., Robson C. N. RT Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. RL J. Biol. Chem. 277:25904-13 (2002). RN [10]; RE0029979. RX PUBMED: 12163482. RA Ueda T., Mawji N. R., Bruchovsky N., Sadar M. D. RT Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. RL J. Biol. Chem. 277:38087-94 (2002). RN [11]; RE0030036. RX PUBMED: 12569365. RA Ngan E. S., Hashimoto Y., Ma Z. Q., Tsai M. J., Tsai S. Y. RT Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. RL Oncogene 22:734-9 (2003). RN [12]; RE0030408. RX PUBMED: 12771131. RA Agoulnik I. U., Krause W. C., Bingman W. E. 3rd, Rahman H. T., Amrikachi M., Ayala G. E., Weigel N. L. RT Repressors of androgen and progesterone receptor action. RL J. Biol. Chem. 278:31136-48 (2003). RN [13]; RE0030537. RX PUBMED: 12799378. RA Amir A. L., Barua M., McKnight N. C., Cheng S., Yuan X., Balk S. P. RT A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. RL J. Biol. Chem. 278:30828-34 (2003). RN [14]; RE0030660. RX PUBMED: 9817600. RA Boruk M., Savory J. G., Hache R. J. RT AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. RL Mol. Endocrinol. 12:1749-63 (1998). RN [15]; RE0031271. RX PUBMED: 11997177. RA Gonzalez M. I., Tovaglieri A., Robins D. M. RT Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct. RL Mol. Cell. Endocrinol. 190:39-49 (2002). RN [16]; RE0031300. RX PUBMED: 12177000. RA Nishida T., Yasuda H. RT PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. RL J. Biol. Chem. 277:41311-7 (2002). RN [17]; RE0031565. RX PUBMED: 14638683. RA Li H., Kim J. H., Koh S. S., Stallcup M. R. RT Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. RL J. Biol. Chem. 279:4212-20 (2004). RN [18]; RE0031583. RX PUBMED: 9233568. RA Morgan G. E., Rowley G., Green P. M., Chisholm M., Giannelli F., Brownlee G. G. RT Further evidence for the importance of an androgen response element in the factor IX promoter. RL Br. J. Haematol. 98:79-85 (1997). RN [19]; RE0031743. RX PUBMED: 11792709. RA Yang F., Li X., Sharma M., Sasaki C. Y., Longo D. L., Lim B., Sun Z. RT Linking beta-catenin to androgen-signaling pathway. RL J. Biol. Chem. 277:11336-44 (2002). RN [20]; RE0031802. RX PUBMED: 12791770. RA Geserick C., Meyer H. A., Barbulescu K., Haendler B. RT Differential modulation of androgen receptor action by deoxyribonucleic acid response elements. RL Mol. Endocrinol. 17:1738-50 (2003). RN [21]; RE0031827. RX PUBMED: 11894840. RA Vanaja D. K., Mitchell S. H., Toft D. O., Young C. Y. RT Effect of geldanamycin on androgen receptor function and stability. RL Cell Stress Chaperones 7:55-64 (2002). RN [22]; RE0033235. RX PUBMED: 15131260. RA Powzaniuk M., McElwee-Witmer S., Vogel R. L., Hayami T., Rutledge S. J., Chen F., Harada S., Schmidt A., Rodan G. A., Freedman L. P., Bai C. RT The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. RL Mol. Endocrinol. 18:2011-23 (2004). RN [23]; RE0033732. RX PUBMED: 11328859. RA Reutens A. T., Fu M., Wang C., Albanese C., McPhaul M. J., Sun Z., Balk S. P., Janne O. A., Palvimo J. J., Pestell R. G. RT Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. RL Mol. Endocrinol. 15:797-811 (2001). RN [24]; RE0033803. RX PUBMED: 12063252. RA Sharma M., Chuang W. W., Sun Z. RT Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. RL J. Biol. Chem. 277:30935-41 (2002). RN [25]; RE0035339. RX PUBMED: 12649293. RA Rahman M. M., Miyamoto H., Takatera H., Yeh S., Altuwaijri S., Chang C. RT Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells. RL J. Biol. Chem. 278:19619-19626 (2003). RN [26]; RE0035340. RX PUBMED: 11818501. RA Zhou Z. X., He B., Hall S. H., Wilson E. M., French F. S. RT Domain interactions between coregulator ARA(70) and the androgen receptor (AR). RL Mol. Endocrinol. 16:287-300 (2002). RN [27]; RE0035341. RX PUBMED: 15514032. RA Hsu C. L., Chen Y. L., Ting H. J., Lin W. J., Yang Z., Zhang Y., Wang L., Wu C. T., Chang H. C., Yeh S., Pimplikar S. W., Chang C. RT Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. RL Mol. Endocrinol. 19:350-361 (2005). RN [28]; RE0035344. RX PUBMED: 11779876. RA He B., Minges J. T., Lee L. W., Wilson E. M. RT The FXXLF motif mediates androgen receptor-specific interactions with coregulators. RL J. Biol. Chem. 277:10226-10235 (2002). RN [29]; RE0035574. RX PUBMED: 14570770. RA Fang H. L., Shenoy S., Duanmu Z., Kocarek T. A., Runge-Morris M. RT Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription. RL Drug Metab. Dispos. 31:1378-1381 (2003). RN [30]; RE0035828. RX PUBMED: 10521447. RA Ning Y. M., Robins D. M. RT AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. RL J. Biol. Chem. 274:30624-30630 (1999). RN [31]; RE0035978. RX PUBMED: 10454563. RA Ma H., Hong H., Huang S. M., Irvine R. A., Webb P., Kushner P. J., Coetzee G. A., Stallcup M. R. RT Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. RL Mol. Cell. Biol. 19:6164-6173 (1999). RN [32]; RE0036207. RX PUBMED: 11719263. RA Beauchemin A. M., Gottlieb B., Beitel L. K., Elhaji Y. A., Pinsky L., Trifiro M. A. RT Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy RL Brain Res. Bull. 56:285-97 (2001). RN [33]; RE0037501. RX PUBMED: 10508170. RA Hittelman A. B., Burakov D., Iniguez-Lluhi J. A., Freedman L. P., Garabedian M. J. RT Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins RL EMBO J. 18:5380-8 (1999). RN [34]; RE0037821. RX PUBMED: 12589937. RA Papaconstantinou A. D., Umbreit T. H., Goering P. L., Brown K. M. RT Effects of 17 alpha-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors RL J. Steroid Biochem. Mol. Biol. 82:305-14 (2002). RN [35]; RE0037852. RX PUBMED: 11792840. RA Ting H. J., Yeh S., Nishimura K., Chang C. RT Supervillin associates with androgen receptor and modulates its transcriptional activity RL Proc. Natl. Acad. Sci. USA 99:661-6 (2002). RN [36]; RE0037874. RX PUBMED: 14749354. RA Tong M., Tai H. H. RT Synergistic induction of the nicotinamide adenine dinucleotide-linked 15-hydroxyprostaglandin dehydrogenase by an androgen and interleukin-6 or forskolin in human prostate cancer cells RL Endocrinology 145:2141-7 (2004). RN [37]; RE0037971. RX PUBMED: 12077349. RA Kotaja N., Karvonen U., Janne O. A., Palvimo J. J. RT PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases RL Mol. Cell. Biol. 22:5222-34 (2002). RN [38]; RE0038115. RX PUBMED: 12123801. RA Karvonen U., Janne O. A., Palvimo J. J. RT Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei RL FEBS Lett. 523:43-7 (2002). RN [39]; RE0038677. RX PUBMED: 15199155. RA Cheng J., Wang D., Wang Z., Yeh E. T. RT SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1 RL Mol. Cell. Biol. 24:6021-8 (2004). RN [40]; RE0038689. RX PUBMED: 11983685. RA Koh S. S., Li H., Lee Y. H., Widelitz R. B., Chuong C. M., Stallcup M. R. RT Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators RL J. Biol. Chem. 277:26031-5 (2002). RN [41]; RE0038999. RX PUBMED: 12483528. RA Segawa T., Nau M. E., Xu L. L., Chilukuri R. N., Makarem M., Zhang W., Petrovics G., Sesterhenn I. A., McLeod D. G., Moul J. W., Vahey M., Srivastava S. RT Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells RL Oncogene 21:8749-58 (2002). RN [42]; RE0039249. RX PUBMED: 9565586. RA Froesch B. A., Takayama S., Reed J. C. RT BAG-1L protein enhances androgen receptor function RL J. Biol. Chem. 273:11660-6 (1998). RN [43]; RE0039350. RX PUBMED: 1544711. RA Ormandy C. J., Clarke C. L., Kelly P. A., Sutherland R. L. RT Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells RL Int. J. Cancer 50:777-82 (1992). RN [44]; RE0039687. RX PUBMED: 10332029. RA Waragai M., Lammers C. H., Takeuchi S., Imafuku I., Udagawa Y., Kanazawa I., Kawabata M., Mouradian M. M., Okazawa H. RT PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival RL Hum. Mol. Genet. 8:977-87 (1999). RN [45]; RE0039746. RX PUBMED: 9813067. RA Lu J., Danielsen M. RT Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein RL J. Biol. Chem. 273:31528-33 (1998). RN [46]; RE0039747. RX PUBMED: 9675141. RA Yeh S., Miyamoto H., Nishimura K., Kang H., Ludlow J., Hsiao P., Wang C., Su C., Chang C. RT Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells RL Biochem. Biophys. Res. Commun. 248:361-7 (1998). RN [47]; RE0039780. RX PUBMED: 14625289. RA Tujague M., Thomsen J. S., Mizuki K., Sadek C. M., Gustafsson J. A. RT The focal adhesion protein vinexin alpha regulates the phosphorylation and activity of estrogen receptor alpha RL J. Biol. Chem. 279:9255-63 (2004). RN [48]; RE0041001. RX PUBMED: 14761944. RA Burgdorf S., Leister P., Scheidtmann K. H. RT TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination RL J. Biol. Chem. 279:17524-34 (2004). RN [49]; RE0041560. RX PUBMED: 12804609. RA Yamamoto T., Sato N., Sekine Y., Yumioka T., Imoto S., Junicho A., Fuse H., Matsuda T. RT Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor RL Biochem. Biophys. Res. Commun. 306:610-5 (2003). RN [50]; RE0041658. RX PUBMED: 11804942. RA Apparao K. B., Lovely L. P., Gui Y., Lininger R. A., Lessey B. A. RT Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome RL Biol. Reprod. 66:297-304 (2002). RN [51]; RE0041662. RX PUBMED: 10779504. RA Fu M., Wang C., Reutens A. T., Wang J., Angeletti R. H., Siconolfi-Baez L., Ogryzko V., Avantaggiati M. L., Pestell R. G. RT p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation RL J. Biol. Chem. 275:20853-60 (2000). RN [52]; RE0041684. RX PUBMED: 12682292. RA Loy C. J., Sim K. S., Yong E. L. RT Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions RL Proc. Natl. Acad. Sci. USA 100:4562-7 (2003). RN [53]; RE0041899. RX PUBMED: 14988433. RA Curtin D., Ferris H. A., Hakli M., Gibson M., Janne O. A., Palvimo J. J., Shupnik M. A. RT Small nuclear RING finger protein stimulates the rat luteinizing hormone-beta promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression RL Mol. Endocrinol. 18:1263-76 (2004). RN [54]; RE0041948. RX PUBMED: 14573606. RA Schrantz N., da Silva Correia J., Fowler B., Ge Q., Sun Z., Bokoch G. M. RT Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling RL J. Biol. Chem. 279:1922-31 (2004). RN [55]; RE0041953. RX PUBMED: 15023052. RA Kumar R., Betney R., Li J., Thompson E. B., McEwan I. J. RT Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF RL Biochemistry 43:3008-13 (2004). RN [56]; RE0041968. RX PUBMED: 9037086. RA Al-Shamma H. A., Arnold A. P. RT Brain-derived neurotrophic factor regulates expression of androgen receptors in perineal motoneurons RL Proc. Natl. Acad. Sci. USA 94:1521-6 (1997). RN [57]; RE0041969. RX PUBMED: 12539223. RA Denmeade S. R., Sokoll L. J., Dalrymple S., Rosen D. M., Gady A. M., Bruzek D., Ricklis R. M., Isaacs J. T. RT Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models RL Prostate 54:249-57 (2003). RN [58]; RE0042010. RX PUBMED: 12351697. RA Jain A., Lam A., Vivanco I., Carey M. F., Reiter R. E. RT Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene RL Mol. Endocrinol. 16:2323-37 (2002). RN [59]; RE0042016. RX PUBMED: 10196362. RA Stenoien D. L., Cummings C. J., Adams H. P., Mancini M. G., Patel K., DeMartino G. N., Marcelli M., Weigel N. L., Mancini M. A. RT Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone RL Hum. Mol. Genet. 8:731-41 (1999). RN [60]; RE0042017. RX PUBMED: 12941817. RA Kasai M., Guerrero-Santoro J., Friedman R., Leman E. S., Getzenberg R. H., DeFranco D. B. RT The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines RL Cancer Res. 63:4927-35 (2003). RN [61]; RE0042019. RX PUBMED: 11922395. RA Mitchell S., Abel P., Madaan S., Jeffs J., Chaudhary K., Stamp G., Lalani el-N. RT Androgen-dependent regulation of human MUC1 mucin expression RL Neoplasia 4:9-18 (2002). RN [62]; RE0042020. RX PUBMED: 12390891. RA Lee Y. S., Kim H. J., Lee H. J., Lee J. W., Chun S. Y., Ko S. K., Lee K. RT Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor RL Biol. Reprod. 67:1580-7 (2002). RN [63]; RE0042021. RX PUBMED: 14664718. RA Hofman K., Swinnen J. V., Claessens F., Verhoeven G., Heyns W. RT The retinoblastoma protein-associated transcription repressor RBaK interacts with the androgen receptor and enhances its transcriptional activity RL J. Mol. Endocrinol. 31:583-96 (2003). RN [64]; RE0042028. RX PUBMED: 15031286. RA Liu Y., Kim B. O., Kao C., Jung C., Dalton J. T., He J. J. RT Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation RL J. Biol. Chem. 279:21766-73 (2004). RN [65]; RE0042031. RX PUBMED: 12970746. RA Lee S. O., Lou W., Hou M., Onate S. A., Gao A. C. RT Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway RL Oncogene 22:7981-8 (2003). RN [66]; RE0042032. RX PUBMED: 12941811. RA Nishimura K., Ting H. J., Harada Y., Tokizane T., Nonomura N., Kang H. Y., Chang H. C., Yeh S., Miyamoto H., Shin M., Aozasa K., Okuyama A., Chang C. RT Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator RL Cancer Res. 63:4888-94 (2003). RN [67]; RE0042033. RX PUBMED: 14609956. RA Sharma M., Li X., Wang Y., Zarnegar M., Huang C. Y., Palvimo J. J., Lim B., Sun Z. RT hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci RL EMBO J. 22:6101-14 (2003). RN [68]; RE0042034. RX PUBMED: 14729952. RA Zhang Y., Yang Y., Yeh S., Chang C. RT ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation RL Mol. Cell. Biol. 24:1044-57 (2004). RN [69]; RE0042050. RX PUBMED: 12051727. RA Lee D. K. RT Androgen receptor enhances myogenin expression and accelerates differentiation RL Biochem. Biophys. Res. Commun. 294:408-13 (2002). RN [70]; RE0042058. RX PUBMED: 10067824. RA Qian Y. M., Song W. C. RT Regulation of estrogen sulfotransferase expression in Leydig cells by cyclic adenosine 3',5'-monophosphate and androgen RL Endocrinology 140:1048-53 (1999). RN [71]; RE0042068. RX PUBMED: 12864730. RA Wafa L. A., Cheng H., Rao M. A., Nelson C. C., Cox M., Hirst M., Sadowski I., Rennie P. S. RT Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system RL Biochem. J. 375:373-83 (2003). RN [72]; RE0042071. RX PUBMED: 12810069. RA Ishitani K., Yoshida T., Kitagawa H., Ohta H., Nozawa S., Kato S. RT p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor RL Biochem. Biophys. Res. Commun. 306:660-5 (2003). RN [73]; RE0042072. RX PUBMED: 10668786. RA Lin C. S., Lau A., Yeh C. C., Chang C. H., Lue T. F. RT Upregulation of L-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences RL DNA Cell Biol. 19:1-7 (2000). RN [74]; RE0042073. RX PUBMED: 15199138. RA Sitz J. H., Tigges M., Baumgartel K., Khaspekov L. G., Lutz B. RT Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4 RL Mol. Cell. Biol. 24:5821-34 (2004). RN [75]; RE0042074. RX PUBMED: 10965888. RA Bonaccorsi L., Carloni V., Muratori M., Salvadori A., Giannini A., Carini M., Serio M., Forti G., Baldi E. RT Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype RL Endocrinology 141:3172-82 (2000). RN [76]; RE0042076. RX PUBMED: 15086535. RL J. Invest. Dermatol 122:555-564 (2004). RN [77]; RE0042078. RX PUBMED: 15041469. RA Lin P., Chang J. T., Ko J. L., Liao S. H., Lo W. S. RT Reduction of androgen receptor expression by benzo[alpha]pyrene and 7,8-dihydro-9,10-epoxy-7,8,9,10-tetrahydrobenzo[alpha]pyrene in human lung cells RL Biochem. Pharmacol. 67:1523-30 (2004). RN [78]; RE0042283. RX PUBMED: 9482849. RA Aarnisalo P., Palvimo J. J., Janne O. A. RT CREB-binding protein in androgen receptor-mediated signaling RL Proc. Natl. Acad. Sci. USA 95:2122-7 (1998). RN [79]; RE0043032. RX PUBMED: 9241247. RA Sun Z., Pan J., Balk S. P. RT Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes RL Nucleic Acids Res. 25:3318-25 (1997). RN [80]; RE0043148. RX PUBMED: 11162897. RA Shen R., Sumitomo M., Dai J., Hardy D. O., Navarro D., Usmani B., Papandreou C. N., Hersh L. B., Shipp M. A., Freedman L. P., Nanus D. M. RT Identification and characterization of two androgen response regions in the human neutral endopeptidase gene RL Mol. Cell. Endocrinol. 170:131-142 (2000). RN [81]; RE0043175. RX PUBMED: 9215398. RA Culig Z., Hobisch A., Hittmair A., Cronauer M. V., Radmayr C., Zhang J., Bartsch G., Klocker H. RT Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells RL Prostate 32:106-14 (1997). RN [82]; RE0043223. RX PUBMED: 10075738. RA Fujimoto N., Yeh S., Kang H. Y., Inui S., Chang H. C., Mizokami A., Chang C. RT Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate RL J. Biol. Chem. 274:8316-21 (1999). RN [83]; RE0043226. RX PUBMED: 12089345. RA Cheng S., Brzostek S., Lee S. R., Hollenberg A. N., Balk S. P. RT Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor RL Mol. Endocrinol. 16:1492-501 (2002). RN [84]; RE0043228. RX PUBMED: 12441355. RA Liao G., Chen L. Y., Zhang A., Godavarthy A., Xia F., Ghosh J. C., Li H., Chen J. D. RT Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT RL J. Biol. Chem. 278:5052-61 (2003). RN [85]; RE0043229. RX PUBMED: 10085091. RA Kang H. Y., Yeh S., Fujimoto N., Chang C. RT Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor RL J. Biol. Chem. 274:8570-6 (1999). RN [86]; RE0043334. RX PUBMED: 12165860. RA Zhang Y., Fondell J. D., Wang Q., Xia X., Cheng A., Lu M. L., Hamburger A. W. RT Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1 RL Oncogene 21:5609-18 (2002). RN [87]; RE0043355. RX PUBMED: 10400640. RA Hsiao P. W., Lin D. L., Nakao R., Chang C. RT The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator RL J. Biol. Chem. 274:20229-34 (1999). RN [88]; RE0043421. RX PUBMED: 11286474. RA Silvy M., Giusti C., Martin P. M., Berthois Y. RT Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells RL Br. J. Cancer 84:936-45 (2001). RN [89]; RE0043425. RX PUBMED: 11266437. RA Lee D. K., Duan H. O., Chang C. RT Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation RL J. Biol. Chem. 276:9978-84 (2001). RN [90]; RE0043455. RX PUBMED: 9067276. RA Swinnen J. V., Esquenet M., Goossens K., Heyns W., Verhoeven G. RT Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP RL Cancer Res. 57:1086-90 (1997). RN [91]; RE0043459. RX PUBMED: 8872471. RA Koshy B., Matilla T., Burright E. N., Merry D. E., Fischbeck K. H., Orr H. T., Zoghbi H. Y. RT Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase RL Hum. Mol. Genet. 5:1311-8 (1996). RN [92]; RE0043470. RX PUBMED: 11884637. RA Matsui D., Sakari M., Sato T., Murayama A., Takada I., Kim M., Takeyama K., Kato S. RT Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain RL Nucleic Acids Res. 30:1387-93 (2002). RN [93]; RE0044547. RX PUBMED: 11719440. RA Wolfgang C. D., Essand M., Lee B., Pastan I. RT T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin RL Cancer Res. 61:8122-6 (2001). RN [94]; RE0047132. RX PUBMED: 11278309. RA Lu M. L., Schneider M. C., Zheng Y., Zhang X., Richie J. P. RT Caveolin-1 interacts with androgen receptor. a positive modulator of androgen receptor mediated transactivation RL J. Biol. Chem. 276:13442-51 (2001). RN [95]; RE0047141. RX PUBMED: 12060666. RA Kotaja N., Karvonen U., Janne O. A., Palvimo J. J. RT The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1 RL J. Biol. Chem. 277:30283-8 (2002). RN [96]; RE0047228. RX PUBMED: 12750453. RA Gao N., Zhang J., Rao M. A., Case T. C., Mirosevich J., Wang Y., Jin R., Gupta A., Rennie P. S., Matusik R. J. RT The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes RL Mol. Endocrinol. 17:1484-507 (2003). RN [97]; RE0047229. RX PUBMED: 15731171. RA Gao S., Lee P., Wang H., Gerald W., Adler M., Zhang L., Wang Y. F., Wang Z. RT The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells RL Mol. Endocrinol. 19:1792-802 (2005). RN [98]; RE0047266. RX PUBMED: 12514133. RA Metzger E., Muller J. M., Ferrari S., Buettner R., Schule R. RT A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer RL EMBO J. 22:270-80 (2003). RN [99]; RE0047765. RX PUBMED: 15790678. RA Lim J. T., Mansukhani M., Weinstein I. B. RT Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. RL Proc. Natl. Acad. Sci. USA 102:5156-5161 (2005). RN [100]; RE0048013. RX PUBMED: 15691881. RA Kim J., Jia L., Stallcup M. R., Coetzee G. A. RT The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. RL J. Mol. Endocrinol. 34:107-118 (2005). RN [101]; RE0048426. RX PUBMED: 15539430. RA Burd C. J., Petre C. E., Moghadam H., Wilson E. M., Knudsen K. E. RT Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. RL Mol. Endocrinol. 19:607-620 (2005). RN [102]; RE0048454. RX PUBMED: 16461912. RA Burd C. J., Petre C. E., Morey L. M., Wang Y., Revelo M. P., Haiman C. A., Lu S., Fenoglio-Preiser C. M., Li J., Knudsen E. S., Wong J., Knudsen K. E. RT Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. RL Proc. Natl. Acad. Sci. USA 103:2190-2195 (2006). RN [103]; RE0048561. RX PUBMED: 15640154. RA Mayeur G. L., Kung W. J., Martinez A., Izumiya C., Chen D. J., Kung H. J. RT Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells. RL J. Biol. Chem. 280:10827-10833 (2005). RN [104]; RE0048562. RX PUBMED: 16603237. RA Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., Zhang Y. RT JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. RL Cell 125:483-495 (2006). RN [105]; RE0048789. RX PUBMED: 12665592. RA Hietakangas V., Ahlskog J. K., Jakobsson A. M., Hellesuo M., Sahlberg N. M., Holmberg C. I., Mikhailov A., Palvimo J. J., Pirkkala L., Sistonen L. RT Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. RL Mol. Cell. Biol. 23:2953-2968 (2003). RN [106]; RE0049351. RX PUBMED: 17192406. RA Nair S. S., Guo Z., Mueller J. M., Koochekpour S., Qiu Y., Tekmal R. R., Schule R., Kung H. J., Kumar R., Vadlamudi R. K. RT PELP1/MNAR enhances androgen receptor functions through LIM-only coactivator FHL2. RL Mol. Endocrinol. 21:613-624 (2007). RN [107]; RE0049373. RX PUBMED: 15919722. RA Hong C. Y., Gong E. Y., Kim K., Suh J. H., Ko H. M., Lee H. J., Choi H. S., Lee K. RT Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1. RL Mol. Endocrinol. 19:2245-2257 (2005). RN [108]; RE0050523. RX PUBMED: 17494760. RA Mahajan N. P., Liu Y., Majumder S., Warren M. R., Parker C. E., Mohler J. L., Earp H. S., Whang Y. E. RT Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. RL Proc. Natl. Acad. Sci. USA 104:8438-8443 (2007). RN [109]; RE0063079. RX PUBMED: 19481544. RA Kang H. B., Choi Y., Lee J. M., Choi K. C., Kim H. C., Yoo J. Y., Lee Y. H., Yoon H. G. RT The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription. RL FEBS Lett. 583:1880-1886 (2009). RN [110]; RE0067200. RX PUBMED: 17202838. RA Jiang A., Yu C., Zhang P., Chen W., Liu W., Hu X., Zhang J. RT p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line. RL Exp. Mol. Med. 38:625-633 (2006). RN [111]; RE0069471. RX PUBMED: 15602573. RA Proikas-Cezanne T., Waddell S., Gaugel A., Frickey T., Lupas A., Nordheim A. RT WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. RL Oncogene 23:9314-9325 (2004). XX //